MIZUHO MEDY CO.,LTD. Logo

MIZUHO MEDY CO.,LTD.

4595 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
鳥栖市藤木町5番地の4
Sector:
Health Care
Industry:
Pharmaceuticals

Description

MIZUHO MEDY Co., Ltd., based in Tosu, Saga, Japan, specializes in in vitro diagnostics, offering a comprehensive range of innovative products. The company is renowned for its advanced nucleic acid amplification tests and rapid immunoassays catering to clinical, research, and agricultural applications. Notable offerings include the Smart Gene® series and the Quick Chaser line, which addresses various pathogens, including SARS-CoV-2 and RSV. Committed to quality, MIZUHO MEDY has achieved ISO 13485 certification for its operations, ensuring adherence to stringent quality management standards. With a focus on technological advancement, the company actively participates in international exhibitions, showcasing its commitment to healthcare innovation and improving diagnostic solutions.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-02 06:17
Inside Information Statement
臨時報告書
Japanese 25.9 KB
2025-03-31 03:44
Internal Control over Financial Reporting
内部統制報告書-第48期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-31 03:41
Regulatory News Service
確認書
Japanese 8.7 KB
2025-03-31 03:37
Annual Report
有価証券報告書-第48期(2024/01/01-2024/12/31)
Japanese 931.6 KB
2024-08-09 06:11
Regulatory News Service
確認書
Japanese 8.7 KB
2024-08-09 06:09
Interim Report
半期報告書-第48期(2024/01/01-2024/12/31)
Japanese 209.8 KB
2024-05-10 06:07
Regulatory News Service
確認書
Japanese 8.7 KB
2024-05-10 06:06
Quarterly Report
四半期報告書-第48期第1四半期(2024/01/01-2024/03/31)
Japanese 169.5 KB
2024-04-01 09:48
Inside Information Statement
臨時報告書
Japanese 21.6 KB
2024-03-29 02:02
Internal Control over Financial Reporting
内部統制報告書-第47期(2023/01/01-2023/12/31)
Japanese 22.5 KB
2024-03-29 01:59
Regulatory News Service
確認書
Japanese 8.7 KB
2024-03-29 01:56
Annual Report
有価証券報告書-第47期(2023/01/01-2023/12/31)
Japanese 967.0 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nippon Shinyaku Co.,Ltd. Logo Nippon Shinyaku Co.,Ltd. Japan 4516
Noile-Immune Biotech Inc. Logo Noile-Immune Biotech Inc. Japan 4893
Novartis AG Logo Novartis AG Switzerland NOVN
Nur Ink Innovations Ltd. Logo Nur Ink Innovations Ltd. Israel NURI
Nxera Pharma Co., Ltd. Logo Nxera Pharma Co., Ltd. Japan 4565
ObsEva SA Logo ObsEva SA Switzerland OBSN
ODI Pharma AB Logo ODI Pharma AB Sweden ODI
Oncolys BioPharma Inc. Logo Oncolys BioPharma Inc. Japan 4588
OncoTherapy Science, Inc. Logo OncoTherapy Science, Inc. Japan 4564
OncoZenge AB Logo OncoZenge AB Sweden ONCOZ